Lv59
1386 积分 2020-08-09 加入
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
1天前
已完结
New payloads drive next-gen antibody–drug conjugates
1天前
已完结
Rethinking ovarian cancer III: the past decade and future directions
3天前
已完结
Structural characterization of a monomethylauristatin-E based ADC that contains 8 drugs conjugated at interchain cysteine residues
22天前
已完结
A renaissance in targeting the PI3K/AKT/mTOR pathway
23天前
已完结
Auristatin S: An Auristatin Payload with Improved Tolerability and Modified Bystander Activity
25天前
已完结
Auristatin S: An Auristatin Payload with Improved Tolerability and Modified Bystander Activity
1个月前
已完结
β-glucuronidase-triggered ortho-hydroxyl-mediated cyclization strategy for the efficient delivery of phenolic payloads in antibody-drug conjugates
1个月前
已完结
From KRASG12D to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design
1个月前
已完结
Systematic Evaluation of Maleimide Spacer Impact on Drug-Linker Deconjugation in Antibody-Drug Conjugates Ex Vivo and In Vivo
1个月前
已完结
皖公网安备34019202002308
